Patient‐Specific Clinical Formulation for Agitation in Alzheimer's Disease: Beyond Group‐Level Evidence

Shunichiro Shinagawa, Tomoyuki Nagata

Open source

DOI
10.1111/psyg.70220
Published
2026-09-23
Container
Psychogeriatrics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/psyg.70220,
  title = {Patient‐Specific Clinical Formulation for Agitation in Alzheimer's Disease: Beyond Group‐Level Evidence},
  author = {Shunichiro Shinagawa and Tomoyuki Nagata},
  year = {2026},
  journal = {Psychogeriatrics},
  doi = {10.1111/psyg.70220},
  url = {https://doi.org/10.1111/psyg.70220}
}

RIS

TY  - JOUR
TI  - Patient‐Specific Clinical Formulation for Agitation in Alzheimer's Disease: Beyond Group‐Level Evidence
AU  - Shunichiro Shinagawa
AU  - Tomoyuki Nagata
PY  - 2026
JO  - Psychogeriatrics
DO  - 10.1111/psyg.70220
UR  - https://doi.org/10.1111/psyg.70220
ER  - 

APA

Shinagawa, S., & Nagata, T. (2026). Patient‐Specific Clinical Formulation for Agitation in Alzheimer's Disease: Beyond Group‐Level Evidence. Psychogeriatrics. https://doi.org/10.1111/psyg.70220

Source records